Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment.
Tarek N; Le Luduec JB; Gallagher MM; Zheng J; Venstrom JM; Chamberlain E; Modak S; Heller G; Dupont B; Cheung NK; Hsu KC; The Journal Of Clinical Investigation, 2012, vol. 122, issue 9, p 3260, ISSN 15588238. ISBN 15588238.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef